Concurrent use of drugs that alter concentrations of boceprevir or telaprevir in the body may contribute to poor response to interferon-based triple therapy for chronic hepatitis C, according to study findings presented at the Digestive Disease Week meeting last week in Orlando.
http://www.hivandhepatitis.com/hepatitis-c/hepatitis-c-topics/hcv-treatment/4120-ddw-2013-drug-interactions-may-compromise-response-to-boceprevir-and-telaprevir
http://www.hivandhepatitis.com/hepatitis-c/hepatitis-c-topics/hcv-treatment/4120-ddw-2013-drug-interactions-may-compromise-response-to-boceprevir-and-telaprevir
No comments:
Post a Comment